Zhejiang Shengyang Science (603703) — Capital Reinvestment Ratio

Latest as of September 2025: 1.96x

Zhejiang Shengyang Science (603703) has a Capital Reinvestment Ratio of 1.96x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥8.25 Million) in capital expenditures (CN¥16.20 Million). See Zhejiang Shengyang Science balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

1.96x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥8.25 Million
CNY

Capital Expenditures

CN¥16.20 Million
CNY

Data as of

Sep 2025
Most recent filing

Zhejiang Shengyang Science Capital Reinvestment Ratio (2012–2023)

This chart tracks Zhejiang Shengyang Science's Capital Reinvestment Ratio across 11 annual periods. Check 603703 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Zhejiang Shengyang Science (2012–2023)

Year-by-year Capital Reinvestment Ratio for Zhejiang Shengyang Science from 2012 to 2023. For live market cap and broader valuation context, see Zhejiang Shengyang Science market cap and net worth.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2023 1.28x CN¥81.30 Million CN¥103.97 Million ▲ +11.4%
2022 1.15x CN¥89.94 Million CN¥103.28 Million ▼ -1.6%
2021 1.17x CN¥76.14 Million CN¥88.88 Million ▲ +29.7%
2020 0.90x CN¥55.06 Million CN¥49.53 Million ▲ +42.3%
2019 0.63x CN¥52.25 Million CN¥33.04 Million ▲ +35.2%
2018 0.47x CN¥62.76 Million CN¥29.36 Million ▲ +98.3%
2017 0.24x CN¥129.96 Million CN¥30.65 Million ▼ -62.1%
2016 0.62x CN¥33.70 Million CN¥20.97 Million ▼ -6.9%
2014 0.67x CN¥66.34 Million CN¥44.34 Million ▼ -26.1%
2013 0.90x CN¥48.66 Million CN¥43.98 Million ▼ -81.4%
2012 4.86x CN¥4.85 Million CN¥23.56 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow